Sandra Hoefgen
Impact in
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
-
- Alzheimer's disease research and treatments
Papers in
-
- Fungal and yeast genetics research 4
- Sphingolipid Metabolism and Signaling 4
- Plant biochemistry and biosynthesis 3
- Prion Diseases and Protein Misfolding 3
-
- Microbial Natural Products and Biosynthesis 6
- Co-authors
- Vito Valiante (17 shared papers)Manuel E. Than (5 shared papers)Sven O. Dahms (3 shared papers)Dirk Roeser (2 shared papers)Karl‐Heinz Gührs (1 shared paper)Bernhard Schlott (1 shared paper)Axel A. Brakhage (3 shared papers)Peter Hortschansky (2 shared papers)
- Journals
- mBio (4 papers)Angewandte Chemie International Edition (2 papers)Journal of Structural Biology (1 paper)RSC Advances (1 paper)Microbial Biotechnology (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Sandra Hoefgen
22 papers receiving 465 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 142
- Physiology 138
- Biotechnology 37
- Molecular Biology 274
- Cell Biology 60
Countries citing papers authored by Sandra Hoefgen
This map shows the geographic impact of Sandra Hoefgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Hoefgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Hoefgen more than expected).
Fields of papers citing papers by Sandra Hoefgen
This network shows the impact of papers produced by Sandra Hoefgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Hoefgen. The network helps show where Sandra Hoefgen may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Hoefgen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 91 | |
| 2 | 2018 | 64 | |
| 3 | 2019 | 40 | |
| 4 | 2021 | 35 | |
| 5 | 2020 | 28 | |
| 6 | 2014 | 24 | |
| 7 | 2020 | 23 | |
| 8 | 2013 | 23 | |
| 9 | 2014 | 23 | |
| 10 | 2014 | 20 | |
| 11 | 2020 | 18 | |
| 12 | 2022 | 16 | |
| 13 | 2020 | 16 | |
| 14 | 2022 | 14 | |
| 15 | 2020 | 13 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2024 | 2 |
About Sandra Hoefgen
Sandra Hoefgen is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Physiology and Biotechnology, having authored 22 papers that have together received 470 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Alzheimer's disease research and treatments (5 papers), Fungal and yeast genetics research (4 papers), Sphingolipid Metabolism and Signaling (4 papers), Chemical synthesis and alkaloids (4 papers), Trace Elements in Health (3 papers), Plant biochemistry and biosynthesis (3 papers) and Prion Diseases and Protein Misfolding (3 papers). The work is most often cited by research in Pharmacology (142 citations), Physiology (138 citations), Biotechnology (37 citations), Molecular Biology (274 citations) and Cell Biology (60 citations). Sandra Hoefgen has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Vito Valiante, Manuel E. Than, Sven O. Dahms, Dirk Roeser, Karl‐Heinz Gührs, Bernhard Schlott, Axel A. Brakhage, Peter Hortschansky, Slavica Janevska and Jun Lin. Their work appears in journals such as mBio, Angewandte Chemie International Edition, Journal of Structural Biology, RSC Advances and Microbial Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.